FDA Puts Abortion Pill Review on Hold Until After Elections
The FDA has decided to postpone a safety review of the abortion drug mifepristone until after the midterm elections. This delay was requested by FDA Commissioner Marty Makary, despite earlier claims that the review was actively underway. The Health and Human Services Department has stated that their